SAPA-GP (Sino-American Pharmaceutical Professionals Association -Greater Philadelphia)

🚀 In today's competitive landscape, life science startups increasingly rely on robust investor networks to thrive. 📅 The Biolabs annual Investor Day 2025 in Philadelphia (April 22, 9 am-4 pm) will unite life science investors with startups from Philly's cutting-edge ecosystem. ⚡ The day will feature pre-selected lightning pitches, engaging poster sessions, a dynamic panel of experts, and exclusive, invite-only networking opportunities. #Lifesciences #Investorday #Phillybiotech #Startupecosystem #BiotechInnovation #Networking #Investorconnections #Biolabs #Philadelphiaevents #Healthcareinnovation #Venturecapital https://lnkd.in/gH9FapTX

In 2024, European companies spent $ 4.6 billion on Chinese innovative pharmaceutical assets vs $ 3.5 billion by the American companies, along with meaningful spending on innovations from South Korea, Japan, and Singapore. Will European companies become the primary licensees of Asian, especially Chinese, biotech innovation? Join #BioVerse Episode 20 that features Chris Sheldon from GSK, Derek Yuan from LYFE Capital, Michael Patten from Harbour BioMed, James Wang from Adcendo, and Angele Maki from Callio Therapeutics to learn from the dealmakers who led many of the recent Asia-to-Europe deals.

In 2024, European companies spent $ 4.6 billion on Chinese innovative pharmaceutical assets vs $ 3.5 billion by the American companies, along with meaningful spending on innovations from South Korea, Japan, and Singapore. Will European companies become the primary licensees of Asian, especially Chinese, biotech innovation? Join #BioVerse Episode 20 that features Chris Sheldon from GSK, Derek Yuan from LYFE Capital, Michael Patten from Harbour BioMed, James Wang from Adcendo, and Angele Maki from Callio Therapeutics to learn from the dealmakers who led many of the recent Asia-to-Europe deals.

👏 As we celebrate the success of AC2025, we extend our deepest gratitude to our sponsors. Your generous support and partnership have been instrumental in making this event a triumph. By bringing together innovators, thought leaders and service providers, you have contributed to advancing collaboration and fostering impactful discussions in our field. Thank you for being an essential part of this achievement! 👍 Here are our sponsors GenScript Apeloa Pharmaceutical HighLight Capital Bristol Myers Squibb Biocytogen CSG Law Yokogawa Fluid Imaging Technologies (Flow Cam) Frontage Laboratories, Inc ICE Bioscience Merck KACTUS AlaR7 (Laura Hong) WuXi XDC #Biopharma #CareerDevelopment #ClinicalDevelopment #Collaboration #Conference #DrugDiscovery #EarlyBird #Ecosystem #Entrepreneurship #Healthcare #Infrastructure #Innovation #Investment #Investors #Leadership #Manufacturing #Mentors #Networking #Pharmaceuticals #Philadelphia #Poster #Project #Register #Regulation #Research #SAPAGP #Therapeutics #Technologies

🚀 Join Us at the 2025 @Philly Cell and Gene Therapy Conference! 🚀 We’re proud to announce that Phyllis Arthur, M.B.A, Executive Vice President & Head of Healthcare Policy and Programs at the Biotechnology Innovation Organization (BIO), will deliver a keynote at this year’s conference! Ms. Arthur leads BIO’s work on healthcare policy, including pricing, access, reimbursement, infectious disease, national security, and capital formation. Before joining BIO, she spent 16 years at Merck, where she helped launch major vaccines like GARDASIL and led a large vaccine sales team. Her career bridges industry, policy, and public health, focusing on driving innovation and access in biotechnology. 📅 Date: June 27-28, 2025 📍 Location: Sheraton Valley Forge Hotel, 480 N Gulph Rd, King of Prussia, PA 🎟 Early bird tickets available now—save over 50%! 🔗 Register here: https://lnkd.in/edm-Gy9f Don’t miss the chance to hear insights from a leader shaping the future of biotech policy and innovation! #cellandgenetherapy #biotechpolicy #vaccines #publichealth #phillyCGT2025 #conference #biopharmaceuticals #conference #keynote

🚀 Join Us at the 2025 @Philly Cell and Gene Therapy Conference! 🚀 We’re excited to announce that Dr. Jim Riley, Professor at the University of Pennsylvania, will be one of our keynote speakers this year! Dr. Riley is a leading expert in T-cell immunotherapy, dedicated to developing engineered T-cell therapies for HIV, autoimmune diseases, and cancer. His research has paved the way for multiple Phase I clinical trials, advancing the use of CAR-T and TCR-based therapies for immune modulation and disease treatment. 📅 Date: June 27-28, 2025 📍 Location: Sheraton Valley Forge Hotel, 480 N Gulph Rd, King of Prussia, PA 🎟 Early bird tickets available now—save over 50%! 🔗 Register here: https://lnkd.in/edm-Gy9f Don’t miss this opportunity to learn from a pioneer in T-cell engineering and connect with experts shaping the future of cell and gene therapy! #celltherapy #Immunotherapy #GeneTherapy #HIVResearch #PhillyCGT2025 #biopharmeuticals #conference #keynotespeaker #networking

📣 SAPA-GP Hosted the 2025 Annual Conference Showcasing Evolving Landscape of Biopharma On March 15, 2025, SAPA-GP hosted its 23rd Annual Conference at the Sheraton Valley Forge Hotel near Philadelphia, attracting over 500 attendees, including life scientists, pharmaceutical professionals, investors, and business leaders. With 58 distinguished speakers across six tracks and three panel discussions, the event covered cutting-edge topics like next-gen drug discovery, AI in pharma innovation, and career development. Dr. Robert Iannone of Jazz Pharmaceuticals delivered a keynote on R&D strategy. Networking highlights included interactive lunches, panel receptions, the President Reception, and a pre-conference workshop on LLMs and Generative AI. The inaugural scientific poster session and a High School Students Business Pitch Competition showcased remarkable talent and ideas. SAPA-GP also celebrated leadership transitions as Dr. Lu Wang became President, and Dr. Xin-Jun Zhang was named President Elect for 2026-2027. The Immediate-past President Dr. Yufeng Li, Senior Director of Clinical Sciences at Vivace Therapeutics, Inc., honored key volunteers with leadership awards. Additionally, 22 students were awarded the SAPA-GP Song Li Scholarship. The conference reaffirmed SAPA-GP's commitment to advancing biopharma innovation and collaboration in the greater Philadelphia area. External media reports: https://lnkd.in/eq4MEYGN https://lnkd.in/eazGKb82 #Biopharma #CareerDevelopment #ClinicalDevelopment #Collaboration #Conference #DrugDiscovery #EarlyBird #Ecosystem #Entrepreneurship #Healthcare #Infrastructure #Innovation #Investment #Investors #Leadership #Manufacturing #Mentors #Networking #Pharmaceuticals #Philadelphia #Poster #Project #Register #Regulation #Research #SAPAGP #Therapeutics #Technologies

🔥 Here is more detail about Song Li scholarship and the award winners. In a remarkable tribute to Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc, SAPA-GP hosted its 1st High School Students Business Pitch Competition on Mar 14, 2025 at the 2025 annual conference. This event showcased the innovative spirit of young minds in the fields of pharmaceutical science, life science, medical science, and biotechnology. Nine teams of high school students, sponsored by SAPA-GP volunteers and speakers, presented their groundbreaking ideas to a panel of esteemed judges: Mahen Gundecha, Kathleen Shay, and Cynthia Cai.  The top prize of $1000 was awarded to BreakUp, a brain biomechanics company founded by Jiong Li. BreakUp aims to mitigate traumatic brain injuries with adaptable helmet systems that reduce linear and rotational shear forces. The company’s mission is to revolutionize brain biotechnology, turning cellular biofluid research into practical, protective equipment for real-world applications. Other participants also benefited greatly from the event, receiving valuable feedback from the judges. This constructive criticism helped them refine their ideas and gain insights into the business world, fostering growth and innovation among the young competitors. The competition was a resounding success, not only in recognizing the winner but also in inspiring and nurturing the next generation of innovators and entrepreneurs. The event highlighted the importance of creativity and critical thinking in addressing real-world challenges, setting a high standard for future competitions and building their entrepreneurial dreams.

👏 We are thrilled to share the incredible success of our SAPA-GP 2025 Annual Conference, held last Friday and Saturday! Please stay tuned for our upcoming reports that will capture all the amazing highlights! Here we are delighted to unveil our inaugural SAPA-GP Song Li Scholarship, an extraordinary opportunity for young, aspiring scientists who actively engage with SAPA-GP through volunteering, business pitches, poster presentations at annual conference, and participation in the Delaware Valley Science Fair (DVSF). This scholarship aims to ignite passion, foster ambition, and empower students to pursue careers in science and embark on science-driven entrepreneurial journeys. Let's inspire the next wave of trailblazing innovators together! This year's winners at the business pitch competition are: 👍 First Place: Jiong Li (BreakUP: Revolutionary Brain BioTechnology) 👍 Second Place: Albert He (Medicube), Alex Li (Stark Shoes), Kaden Liu (Nervana). 👍 Onsite Presenters: Rickey Su, Arnav Chamunya, Aarav Chamunya (HealthLink) Katie Sun, Esha Ravi, Emmy Silverman (AutiPilot) Yamu Xi (Kairo) Asher Wang (NEXUS Omics) Delancey Zhao (Wellsync App). We thank our wonderful and highly professional judges: 🧨 Mahen Gundecha, Chief business office, Exegenesis Bio 🧨 Kathleen Shay, Stem educator, Professional learning and Community Mediator 🧨 Xiaojia Cynthia Cai, Healthcare investor, Board Director& Senior Advisor. #Biopharma #CareerDevelopment #ClinicalDevelopment #Collaboration #Conference #DrugDiscovery #EarlyBird #Ecosystem #Entrepreneurship #Healthcare #Infrastructure #Innovation #Investment #Investors #Leadership #Manufacturing #Mentors #Networking #Pharmaceuticals #Philadelphia #Poster #Project #Register #Regulation #Research #SAPAGP #Therapeutics #Technologies

#Bioverse Episode 19 just had a wonderful discussion with the top-ranked sell-side analyst Umer Raffat from Evercore, industry veteran CEO & founder Xiayang Qiu from Regor Therapeutics Group, and obesity biopharma intelligence expert Stephen Hansen from BioCentury Inc. to share their insights on the current trends and key debate in the #Obesity drug development. Thank you all for your participation! 👏 Here is the highlight of the #Bioverse EP19 and hopefully you enjoyed it! 🥂